The intracutaneous growth of murine lymphomas: epidermal invasion is characteristic of multiple tumor phenotypes
- PMID: 6237158
- DOI: 10.1111/1523-1747.ep12340368
The intracutaneous growth of murine lymphomas: epidermal invasion is characteristic of multiple tumor phenotypes
Abstract
Affinity of lymphoid cells for the epidermis (epidermotropism) is characteristic of the cutaneous T-cell lymphomas, mycosis fungoides and the Sézary syndrome. Consistent with numerous studies indicating that mycosis fungoides is a neoplasm of OKT4+T8- ("helper/inducer") T lymphocytes is the possibility that epidermotropism is a phenotypic hallmark of this subset of malignant T cells. This proposal was investigated in mice using 8 phenotypically characterized lymphomas of BALB/c origin: 3 histiocytic (phagocytic, lysozyme-positive, FcR+, Ig-, Thy 1-), 1 B-cell (IgM+, FcR+, Thy 1-), and 4 T-cell (Ig-, Thy 1+) lines, including 1 with markers of mouse helper/inducer T cells (Lyt1+23-), 2 with suppressor/cytotoxic markers (Lyt1-23+), and 1 with markers of immature thymocytes (Lyt1+23+). The intracutaneous growth pattern of these lines was studied on hematoxylin and eosin-stained sections through the centers of tumors obtained at times after intradermal injection into parallel groups of syngeneic mice. All of these lymphomas manifested variable epidermotropism that followed a typical sequence. Following dermal growth and spread to the dermal-epidermal junction, tumor cells appeared within the stratum spinosum. Subsequently, collections of cells appeared in spaces within the epidermis (Pautrier-like microabscesses) in tumors greater than 2 cm in diameter, coincident with early epidermal necrosis. Thus, in this animal model it is clear that the intraepidermal invasion/growth does not correlate with the helper/inducer T-cell surface phenotype. These observations are nonetheless consistent with recent studies using monoclonal antibodies to cell surface antigens which have demonstrated a heterogeneity of lymphoid cell subsets within the epidermis in lesions of mycosis fungoides and of other malignant and benign dermatoses.
Similar articles
-
[Cells in the epidermotropic lymphomas (mycosis fungoides and Sézary syndrome. Study using monoclonal antibodies].Nouv Presse Med. 1982 Oct 16;11(41):3033-8. Nouv Presse Med. 1982. PMID: 6755391 French.
-
Demonstration of a subpopulation of Ia+ T-helper cells in mycosis fungoides and the Sézary syndrome.Am J Dermatopathol. 1983 Apr;5(2):135-43. doi: 10.1097/00000372-198304000-00011. Am J Dermatopathol. 1983. PMID: 6224436
-
Expression of T-follicular helper markers in sequential biopsies of progressive mycosis fungoides and other primary cutaneous T-cell lymphomas.Am J Dermatopathol. 2015 Feb;37(2):115-21. doi: 10.1097/DAD.0000000000000258. Am J Dermatopathol. 2015. PMID: 25406852
-
Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers.J Am Acad Dermatol. 2014 Feb;70(2):205.e1-16; quiz 221-2. doi: 10.1016/j.jaad.2013.07.049. J Am Acad Dermatol. 2014. PMID: 24438969 Review.
-
Cutaneous T cell lymphoma differing from classical mycosis fungoides and Sézary syndrome: clinical, histological and immunohistochemical studies of six cases.J Dermatol. 1990 Apr;17(4):226-34. doi: 10.1111/j.1346-8138.1990.tb01630.x. J Dermatol. 1990. PMID: 2195088 Review.
Cited by
-
Small, freshly arrived histiocytes in cutaneous and mucosal herpetic lesions.Arch Dermatol Res. 1996 Aug;288(9):500-6. doi: 10.1007/BF02505244. Arch Dermatol Res. 1996. PMID: 8874742
-
Simultaneous integrated boost with helical arc radiotherapy of total skin (HEARTS) to treat cutaneous manifestations of advanced, therapy-refractory cutaneous lymphoma and leukemia - dosimetry comparison of different regimens and clinical application.Radiat Oncol. 2019 Jan 28;14(1):17. doi: 10.1186/s13014-019-1220-5. Radiat Oncol. 2019. PMID: 30691490 Free PMC article.
-
Understanding Cell Lines, Patient-Derived Xenograft and Genetically Engineered Mouse Models Used to Study Cutaneous T-Cell Lymphoma.Cells. 2022 Feb 9;11(4):593. doi: 10.3390/cells11040593. Cells. 2022. PMID: 35203244 Free PMC article. Review.
-
Epidermotropic marginal zone lymphoma: An uncommon cutaneous B-cell lymphoma responsive to rituximab.JAAD Case Rep. 2017 Sep 23;3(6):474-476. doi: 10.1016/j.jdcr.2017.06.024. eCollection 2017 Nov. JAAD Case Rep. 2017. PMID: 28971136 Free PMC article. No abstract available.
-
Sézary syndrome patient-derived models allow drug selection for personalized therapy.Blood Adv. 2022 Jun 14;6(11):3410-3421. doi: 10.1182/bloodadvances.2021006860. Blood Adv. 2022. PMID: 35413113 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical